title: Implantable cardioverter-defibrillator efficacy in Chagas disease patients depends not only on the device performance: optimizing the adjunct therapy is essential.
authors.affiliation: Heart Institute (InCor)-Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Department of Cardiac Pacing. Av. Enéas de Carvalho Aguiar, 44-CEP 05403-000, São Paulo, SP, Brazil martino@incor.usp.br.
authors.forename: Martino
authors.initials: M
authors.lastname: Martinelli
mesh_terms: D001145:Arrhythmias, Cardiac / Q000517:prevention & control*; D002598:Chagas Cardiomyopathy / Q000628:therapy*; D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D017147:Defibrillators, Implantable; D004554:Electric Countershock / Q000295:instrumentation*; D005260:Female; D006801:Humans; D008297:Male